According to the data from Kaplan–Meir plotter, SFTPD expression was negatively linked to the high overall survival rate in breast cancer patients with Luminal-A grade-1 and grade-2 cancers (Figure 4B, p < 0.05; Figure S3B in Supplementary Material, p < 0.05). This evidence concerns the gene SFTPD and cancer.